Compare ESPR & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ESPR | RFI |
|---|---|---|
| Founded | 2008 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 898.5M | 294.2M |
| IPO Year | 2013 | N/A |
| Metric | ESPR | RFI |
|---|---|---|
| Price | $3.87 | $10.92 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $6.86 | N/A |
| AVG Volume (30 Days) | ★ 6.5M | 69.8K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $303,802,000.00 | N/A |
| Revenue This Year | $25.45 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.83 | N/A |
| 52 Week Low | $0.69 | $9.62 |
| 52 Week High | $4.13 | $12.52 |
| Indicator | ESPR | RFI |
|---|---|---|
| Relative Strength Index (RSI) | 61.15 | 29.91 |
| Support Level | $3.72 | $11.06 |
| Resistance Level | $4.00 | $11.46 |
| Average True Range (ATR) | 0.26 | 0.11 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 75.24 | 5.42 |
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.